Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $47.5 million.

  • Haemonetics' Shares Outstanding (Weighted Average) fell 633.42% to $47.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $47.5 million, marking a year-over-year decrease of 633.42%. This contributed to the annual value of $50.3 million for FY2025, which is 74.15% down from last year.
  • According to the latest figures from Q4 2025, Haemonetics' Shares Outstanding (Weighted Average) is $47.5 million, which was down 633.42% from $47.8 million recorded in Q3 2025.
  • Haemonetics' 5-year Shares Outstanding (Weighted Average) high stood at $51.2 million for Q3 2022, and its period low was $47.5 million during Q4 2025.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $50.8 million (2023), whereas its average is $50.4 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 103.34% in 2021, then tumbled by 633.42% in 2025.
  • Over the past 5 years, Haemonetics' Shares Outstanding (Weighted Average) (Quarter) stood at $51.0 million in 2021, then fell by 0.28% to $50.9 million in 2022, then fell by 0.25% to $50.8 million in 2023, then fell by 0.12% to $50.7 million in 2024, then fell by 6.33% to $47.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $47.5 million for Q4 2025, versus $47.8 million for Q3 2025 and $48.1 million for Q2 2025.